{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:59:42Z","timestamp":1793653182814,"version":"4.5.1"},"reference-count":149,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T00:00:00Z","timestamp":1414713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jhep.2014.10.039","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T20:00:26Z","timestamp":1414872026000},"page":"720-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1545,"title":["Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"62","author":[{"given":"Michal","family":"Pawlak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Staels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.10.039_b0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.10.039_b0010","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1073\/pnas.91.15.7355","article-title":"Differential expression and activation of a family of murine peroxisome proliferator-activated receptors","volume":"91","author":"Kliewer","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.039_b0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis","volume":"116","author":"Lefebvre","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.10.039_b0020","doi-asserted-by":"crossref","first-page":"28918","DOI":"10.1074\/jbc.M910350199","article-title":"Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting","volume":"275","author":"Hashimoto","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0025","doi-asserted-by":"crossref","first-page":"50237","DOI":"10.1074\/jbc.M201208200","article-title":"Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production","volume":"277","author":"Xu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0030","doi-asserted-by":"crossref","first-page":"16154","DOI":"10.1074\/jbc.M400346200","article-title":"Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate","volume":"279","author":"Gervois","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/jhep.2003.50307","article-title":"Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice","volume":"38","author":"Ip","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.039_b0040","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ncpcardio1278","article-title":"Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease","volume":"5","author":"Staels","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.jhep.2014.10.039_b0045","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/hep.26461","article-title":"Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"58","author":"Staels","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.039_b0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/bbrc.1994.1222","article-title":"Structure of the mouse peroxisome proliferator activated receptor alpha gene","volume":"199","author":"Gearing","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2014.10.039_b0055","doi-asserted-by":"crossref","first-page":"44495","DOI":"10.1074\/jbc.M105945200","article-title":"P38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response","volume":"276","author":"Barger","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0060","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1210\/me.2006-0025","article-title":"The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis","volume":"20","author":"Hummasti","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jhep.2014.10.039_b0065","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1073\/pnas.90.4.1440","article-title":"Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor","volume":"90","author":"Gearing","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.039_b0070","doi-asserted-by":"crossref","first-page":"25252","DOI":"10.1074\/jbc.272.40.25252","article-title":"DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5\u2032-flanking region","volume":"272","author":"Juge-Aubry","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0075","doi-asserted-by":"crossref","first-page":"15901","DOI":"10.1074\/jbc.274.22.15901","article-title":"Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein","volume":"274","author":"Dowell","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0080","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1210\/me.2003-0327","article-title":"The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha","volume":"18","author":"Blanquart","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jhep.2014.10.039_b0085","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1074\/jbc.M109.078311","article-title":"SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR","volume":"285","author":"Pourcet","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0090","doi-asserted-by":"crossref","first-page":"13919","DOI":"10.1073\/pnas.241410198","article-title":"Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors","volume":"98","author":"Xu","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.039_b0095","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1097-2765(00)80448-7","article-title":"Asymmetry in the PPARgamma\/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors","volume":"5","author":"Gampe","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2014.10.039_b0100","doi-asserted-by":"crossref","first-page":"e33643","DOI":"10.1371\/journal.pone.0033643","article-title":"Structural insights into human peroxisome proliferator activated receptor delta (PPAR-delta) selective ligand binding","volume":"7","author":"Batista","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2014.10.039_b0105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0969-2126(01)00634-7","article-title":"Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family","volume":"9","author":"Cronet","year":"2001","journal-title":"Structure"},{"key":"10.1016\/j.jhep.2014.10.039_b0110","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1172\/JCI39019","article-title":"Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice","volume":"119","author":"Leuenberger","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.10.039_b0115","doi-asserted-by":"crossref","first-page":"24698","DOI":"10.1074\/jbc.271.40.24698","article-title":"Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene","volume":"271","author":"Fan","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0120","doi-asserted-by":"crossref","first-page":"15639","DOI":"10.1074\/jbc.273.25.15639","article-title":"Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism","volume":"273","author":"Fan","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0125","doi-asserted-by":"crossref","first-page":"23975","DOI":"10.1074\/jbc.270.41.23975","article-title":"Differential activation of peroxisome proliferator-activated receptors by eicosanoids","volume":"270","author":"Yu","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0014-5793(00)01364-8","article-title":"Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner","volume":"471","author":"Delerive","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhep.2014.10.039_b0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cmet.2005.04.002","article-title":"\u201cNew\u201d hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis","volume":"1","author":"Chakravarthy","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2014.10.039_b0140","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cell.2009.05.036","article-title":"Identification of a physiologically relevant endogenous ligand for PPARalpha in liver","volume":"138","author":"Chakravarthy","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2014.10.039_b0145","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1194\/jlr.M800614-JLR200","article-title":"Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity","volume":"50","author":"Sapiro","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2014.10.039_b0150","doi-asserted-by":"crossref","first-page":"13087","DOI":"10.1074\/jbc.M800533200","article-title":"Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis","volume":"283","author":"Reid","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0155","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1475-2840-12-82","article-title":"Selective peroxisome proliferator-activated receptor alpha modulators (SPPARMalpha): the next generation of peroxisome proliferator-activated receptor alpha-agonists","volume":"12","author":"Fruchart","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jhep.2014.10.039_b0160","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0165","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1517\/13543784.2014.954034","article-title":"GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes","volume":"23","author":"Cariou","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jhep.2014.10.039_b0170","doi-asserted-by":"crossref","first-page":"11836","DOI":"10.1073\/pnas.182426699","article-title":"Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator","volume":"99","author":"Surapureddi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.039_b0175","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.27297","article-title":"The transrepressive activity of Pparalpha is necessary and sufficient to prevent liver fibrosis","volume":"60","author":"Pawlak","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.039_b0180","doi-asserted-by":"crossref","first-page":"24427","DOI":"10.1074\/jbc.M402391200","article-title":"Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver","volume":"279","author":"Jia","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0185","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/sj.emboj.7600209","article-title":"In vivo activation of PPAR target genes by RXR homodimers","volume":"23","author":"IJpenberg","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2014.10.039_b0190","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/MCB.06175-11","article-title":"Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor alpha in mouse liver reveals extensive sharing of binding sites","volume":"32","author":"Boergesen","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2014.10.039_b0195","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1093\/nar\/gkq012","article-title":"Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis","volume":"38","author":"van der Meer","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2014.10.039_b0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cbi.2013.11.006","article-title":"A map of the PPARalpha transcription regulatory network for primary human hepatocytes","volume":"209","author":"McMullen","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jhep.2014.10.039_b0205","doi-asserted-by":"crossref","first-page":"e6796","DOI":"10.1371\/journal.pone.0006796","article-title":"Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human","volume":"4","author":"Rakhshandehroo","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2014.10.039_b0210","doi-asserted-by":"crossref","first-page":"26839","DOI":"10.1155\/2007\/26839","article-title":"Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling","volume":"2007","author":"Rakhshandehroo","year":"2007","journal-title":"PPAR Res"},{"key":"10.1016\/j.jhep.2014.10.039_b0215","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","article-title":"Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1","volume":"274","author":"Delerive","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0220","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1073\/pnas.0806742106","article-title":"PPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaB","volume":"106","author":"Bougarne","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.039_b0225","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/endo.142.8.8340","article-title":"PPARalpha and GR differentially down-regulate the expression of nuclear factor-kappaB-responsive genes in vascular endothelial cells","volume":"142","author":"Xu","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2014.10.039_b0230","doi-asserted-by":"crossref","first-page":"33471","DOI":"10.1074\/jbc.M102839200","article-title":"Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box\/enhancer-binding protein beta","volume":"276","author":"Gervois","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0235","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.cmet.2011.10.001","article-title":"PPARalpha-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway","volume":"14","author":"Oka","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2014.10.039_b0240","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4161\/cc.11.5.19210","article-title":"Suppression of ERR targets by a PPARalpha\/Sirt1 complex in the failing heart","volume":"11","author":"Oka","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jhep.2014.10.039_b0245","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1074\/jbc.M112.437525","article-title":"Peroxisome proliferator-activated receptor alpha positively regulates complement C3 expression but inhibits tumor necrosis factor alpha-mediated activation of C3 gene in mammalian hepatic-derived cells","volume":"288","author":"Mogilenko","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0250","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0092-8674(94)90252-6","article-title":"Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein","volume":"79","author":"Schaffer","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2014.10.039_b0255","doi-asserted-by":"crossref","first-page":"28210","DOI":"10.1074\/jbc.272.45.28210","article-title":"Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators","volume":"272","author":"Martin","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0260","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1074\/jbc.274.7.3970","article-title":"Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene","volume":"274","author":"Frohnert","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0265","doi-asserted-by":"crossref","first-page":"16710","DOI":"10.1074\/jbc.273.27.16710","article-title":"Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner","volume":"273","author":"Motojima","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0270","doi-asserted-by":"crossref","first-page":"26821","DOI":"10.1074\/jbc.M111295200","article-title":"The gene encoding the Acyl-CoA-binding protein is activated by peroxisome proliferator-activated receptor gamma through an intronic response element functionally conserved between humans and rodents","volume":"277","author":"Helledie","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0275","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1194\/jlr.M900058-JLR200","article-title":"L-FABP directly interacts with PPARalpha in cultured primary hepatocytes","volume":"50","author":"Hostetler","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2014.10.039_b0280","doi-asserted-by":"crossref","first-page":"938401","DOI":"10.1155\/2013\/938401","article-title":"Interactions between human liver fatty acid binding protein and peroxisome proliferator activated receptor selective drugs","volume":"2013","author":"Velkov","year":"2013","journal-title":"PPAR Res"},{"key":"10.1016\/j.jhep.2014.10.039_b0285","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1073\/pnas.051619898","article-title":"Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha \u2013 and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus","volume":"98","author":"Wolfrum","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.039_b0290","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/bj3540189","article-title":"Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway","volume":"354","author":"Louet","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2014.10.039_b0295","doi-asserted-by":"crossref","first-page":"8560","DOI":"10.1074\/jbc.273.15.8560","article-title":"Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor","volume":"273","author":"Mascaro","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0300","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/bj20020851","article-title":"Control of human carnitine palmitoyltransferase II gene transcription by peroxisome proliferator-activated receptor through a partially conserved peroxisome proliferator-responsive element","volume":"369","author":"Barrero","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2014.10.039_b0305","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1073\/pnas.91.23.11012","article-title":"The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression","volume":"91","author":"Gulick","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.039_b0310","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1074\/jbc.273.10.5678","article-title":"Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)","volume":"273","author":"Aoyama","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0315","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/283397a0","article-title":"Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens","volume":"283","author":"Reddy","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.10.039_b0320","doi-asserted-by":"crossref","first-page":"42485","DOI":"10.1074\/jbc.M106480200","article-title":"Human peroxisome proliferator-activated receptor alpha (PPARalpha) supports the induction of peroxisome proliferation in PPARalpha-deficient mouse liver","volume":"276","author":"Yu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0325","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/carcin\/bgi329","article-title":"Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis","volume":"27","author":"Morimura","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhep.2014.10.039_b0330","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1128\/MCB.00317-07","article-title":"Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation","volume":"27","author":"Shah","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2014.10.039_b0335","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0021-9150(82)90096-X","article-title":"Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment","volume":"43","author":"De La Iglesia","year":"1982","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jhep.2014.10.039_b0340","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0021-9150(83)90169-7","article-title":"Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients","volume":"46","author":"Blumcke","year":"1983","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jhep.2014.10.039_b0345","doi-asserted-by":"crossref","first-page":"e45259","DOI":"10.1371\/journal.pone.0045259","article-title":"Use of fibrates and cancer risk: a systematic review and meta-analysis of 17 long-term randomized placebo-controlled trials","volume":"7","author":"Bonovas","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2014.10.039_b0350","doi-asserted-by":"crossref","first-page":"18767","DOI":"10.1016\/S0021-9258(17)32234-2","article-title":"Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids","volume":"269","author":"Rodriguez","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0355","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI6223","article-title":"Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting","volume":"103","author":"Kersten","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.10.039_b0360","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI3949","article-title":"A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice","volume":"102","author":"Djouadi","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.10.039_b0365","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2014.10.039_b0370","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","article-title":"The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man","volume":"8","author":"Galman","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2014.10.039_b0375","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1002\/j.1460-2075.1996.tb00918.x","article-title":"PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene","volume":"15","author":"Schoonjans","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2014.10.039_b0380","doi-asserted-by":"crossref","first-page":"13470","DOI":"10.1074\/jbc.270.22.13470","article-title":"Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III","volume":"270","author":"Hertz","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0385","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/ATVBAHA.110.220723","article-title":"Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia","volume":"31","author":"Caron","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2014.10.039_b0390","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI200419992","article-title":"Foxo1 mediates insulin action on apoC-III and triglyceride metabolism","volume":"114","author":"Altomonte","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.10.039_b0395","doi-asserted-by":"crossref","first-page":"E421","DOI":"10.1152\/ajpendo.00157.2006","article-title":"PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1","volume":"292","author":"Qu","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhep.2014.10.039_b0400","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1172\/JCI118687","article-title":"Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice","volume":"97","author":"Berthou","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.10.039_b0405","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.ATV.12.3.286","article-title":"Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat","volume":"12","author":"Staels","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jhep.2014.10.039_b0410","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1074\/jbc.272.43.27307","article-title":"Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice","volume":"272","author":"Peters","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0415","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI118118","article-title":"Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor","volume":"96","author":"Vu-Dac","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.10.039_b0420","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2004.05.003","article-title":"Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5","volume":"319","author":"Fruchart-Najib","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2014.10.039_b0425","doi-asserted-by":"crossref","first-page":"27941","DOI":"10.1074\/jbc.M403240200","article-title":"ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis","volume":"279","author":"Schaap","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0430","doi-asserted-by":"crossref","first-page":"21553","DOI":"10.1074\/jbc.M411412200","article-title":"Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase","volume":"280","author":"Merkel","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0435","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jhep.2014.10.039_b0440","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.bbalip.2009.03.015","article-title":"Differential regulation of the human versus the mouse apolipoprotein AV gene by PPARalpha. Implications for the study of pharmaceutical modifiers of hypertriglyceridemia in mice","volume":"1791","author":"Prieur","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.10.039_b0445","doi-asserted-by":"crossref","first-page":"17982","DOI":"10.1074\/jbc.M212191200","article-title":"Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators","volume":"278","author":"Vu-Dac","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0450","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1194\/jlr.M034132","article-title":"Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy","volume":"54","author":"Brautbar","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2014.10.039_b0455","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.atherosclerosis.2011.08.015","article-title":"Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia","volume":"219","author":"Brautbar","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jhep.2014.10.039_b0460","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/ATVBAHA.107.140103","article-title":"Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study","volume":"27","author":"Lai","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2014.10.039_b0465","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.atherosclerosis.2009.02.024","article-title":"The \u22121131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial study","volume":"206","author":"Cardona","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jhep.2014.10.039_b0470","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Ferre","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jhep.2014.10.039_b0475","doi-asserted-by":"crossref","first-page":"21466","DOI":"10.1074\/jbc.M110.209973","article-title":"Human SREBP1c expression in liver is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha)","volume":"286","author":"Fernandez-Alvarez","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0480","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-2275(20)31655-2","article-title":"Disturbances in the normal regulation of SREBP-sensitive genes in PPAR alpha-deficient mice","volume":"42","author":"Patel","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2014.10.039_b0485","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1073\/pnas.93.18.9443","article-title":"Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression","volume":"93","author":"Miller","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.039_b0490","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BJ20041896","article-title":"A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver","volume":"389","author":"Knight","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2014.10.039_b0495","doi-asserted-by":"crossref","first-page":"11245","DOI":"10.1073\/pnas.0404297101","article-title":"Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.039_b0500","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1101\/gad.844900","article-title":"Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta","volume":"14","author":"Repa","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2014.10.039_b0505","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1074\/jbc.M709471200","article-title":"Peroxisome proliferator-activated receptor alpha deficiency abolishes the response of lipogenic gene expression to re-feeding: restoration of the normal response by activation of liver X receptor alpha","volume":"283","author":"Hebbachi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0510","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1074\/jbc.274.15.10505","article-title":"Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain","volume":"274","author":"Juge-Aubry","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0515","doi-asserted-by":"crossref","first-page":"10102","DOI":"10.1073\/pnas.131200398","article-title":"Glucagon receptor activates extracellular signal-regulated protein kinase 1\/2 via cAMP-dependent protein kinase","volume":"98","author":"Jiang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.039_b0520","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1210\/mend.14.12.0575","article-title":"Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators","volume":"14","author":"Lazennec","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jhep.2014.10.039_b0525","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nature09584","article-title":"MTORC1 controls fasting-induced ketogenesis and its modulation by ageing","volume":"468","author":"Sengupta","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.10.039_b0530","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.25537","article-title":"S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver","volume":"55","author":"Kim","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.039_b0535","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1194\/jlr.M036103","article-title":"Nutrient-dependent phosphorylation channels lipid synthesis to regulate PPARalpha","volume":"54","author":"Jensen-Urstad","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2014.10.039_b0540","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1042\/BJ20040955","article-title":"Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinase","volume":"384","author":"Bronner","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2014.10.039_b0545","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1753-0407.2009.00043.x","article-title":"Glucose represses PPARalpha gene expression via AMP-activated protein kinase but not via p38 mitogen-activated protein kinase in the pancreatic beta-cell","volume":"1","author":"Joly","year":"2009","journal-title":"J Diabetes"},{"key":"10.1016\/j.jhep.2014.10.039_b0550","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1677\/jme.1.01965","article-title":"Glucose-induced repression of PPARalpha gene expression in pancreatic beta-cells involves PP2A activation and AMPK inactivation","volume":"36","author":"Ravnskjaer","year":"2006","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.jhep.2014.10.039_b0555","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.2337\/db05-1322","article-title":"Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha","volume":"55","author":"Yoon","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2014.10.039_b0560","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2014.10.039_b0565","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/en.2007-1339","article-title":"Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor-alpha control of the acute-phase response","volume":"149","author":"Mansouri","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2014.10.039_b0570","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.23337","article-title":"Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity","volume":"51","author":"Stienstra","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.039_b0575","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jhep.2006.11.019","article-title":"The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver","volume":"46","author":"Stienstra","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.10.039_b0580","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1182\/blood-2002-06-1762","article-title":"Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C\/EBP-beta complex formation","volume":"101","author":"Kleemann","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2014.10.039_b0585","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jhep.2007.09.009","article-title":"Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study","volume":"48","author":"Allard","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.10.039_b0590","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.bbalip.2011.10.016","article-title":"Roles of PPARs in NAFLD: potential therapeutic targets","volume":"1821","author":"Tailleux","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.10.039_b0595","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/hep.20170","article-title":"Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice","volume":"39","author":"Ip","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.039_b0600","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/carcin\/21.4.823","article-title":"Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis","volume":"21","author":"Peters","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhep.2014.10.039_b0605","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1016\/j.febslet.2013.09.046","article-title":"PPARalpha regulates the production of serum Vanin-1 by liver","volume":"587","author":"Rommelaere","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhep.2014.10.039_b0610","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2014.04.013","article-title":"PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism","volume":"61","author":"van Diepen","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.10.039_b0615","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.26732","article-title":"Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia","volume":"59","author":"Jha","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.039_b0620","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1210\/me.2005-0494","article-title":"Fat aussie\u2013a new Alstrom syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis","volume":"20","author":"Arsov","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jhep.2014.10.039_b0625","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/j.1440-1746.2009.05996.x","article-title":"Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice","volume":"24","author":"Larter","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.10.039_b0630","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1093\/hmg\/ddi235","article-title":"Alms1-disrupted mice recapitulate human Alstrom syndrome","volume":"14","author":"Collin","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhep.2014.10.039_b0635","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1440-1746.2011.06939.x","article-title":"Peroxisome proliferator-activated receptor-alpha agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis","volume":"27","author":"Larter","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.10.039_b0640","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3945\/jn.110.135210","article-title":"PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver","volume":"141","author":"Abdelmegeed","year":"2011","journal-title":"J Nutr"},{"key":"10.1016\/j.jhep.2014.10.039_b0645","doi-asserted-by":"crossref","first-page":"16638","DOI":"10.1074\/jbc.275.22.16638","article-title":"Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity","volume":"275","author":"Guerre-Millo","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0650","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI11497","article-title":"PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice","volume":"107","author":"Tordjman","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.10.039_b0655","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/en.2003-1015","article-title":"Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies","volume":"145","author":"Haluzik","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2014.10.039_b0660","doi-asserted-by":"crossref","first-page":"115","DOI":"10.33549\/physiolres.930744","article-title":"PPAR-alpha and insulin sensitivity","volume":"55","author":"Haluzik","year":"2006","journal-title":"Physiol Res"},{"key":"10.1016\/j.jhep.2014.10.039_b0665","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jhep.2005.10.033","article-title":"Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates","volume":"44","author":"Shiri-Sverdlov","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.10.039_b0670","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/ATVBAHA.110.220525","article-title":"Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice","volume":"31","author":"Lalloyer","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2014.10.039_b0675","doi-asserted-by":"crossref","first-page":"e44345","DOI":"10.1371\/journal.pone.0044345","article-title":"Hepatic lipid accumulation alters global histone h3 lysine 9 and 4 trimethylation in the peroxisome proliferator-activated receptor alpha network","volume":"7","author":"Jun","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2014.10.039_b0680","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/hep.510270313","article-title":"Fibrogenic effect of oxidative stress on rat hepatic stellate cells","volume":"27","author":"Svegliati Baroni","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.039_b0685","doi-asserted-by":"crossref","first-page":"33881","DOI":"10.1074\/jbc.274.48.33881","article-title":"Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells","volume":"274","author":"De Bleser","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.10.039_b0690","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbrc.2004.09.110","article-title":"PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats","volume":"324","author":"Toyama","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2014.10.039_b0695","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jhep.2011.12.008","article-title":"PPARalpha activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats","volume":"56","author":"Rodriguez-Vilarrupla","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.10.039_b0700","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.dld.2007.10.002","article-title":"A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease","volume":"40","author":"Fernandez-Miranda","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2014.10.039_b0705","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/01.tp.0000166009.77444.f3","article-title":"Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation","volume":"80","author":"Nakamuta","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2014.10.039_b0710","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0168-8278(99)80243-8","article-title":"A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis","volume":"31","author":"Basaranoglu","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.10.039_b0715","first-page":"1464","article-title":"Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study","volume":"23","author":"Laurin","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.039_b0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0220001","article-title":"Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences","volume":"22","author":"Holden","year":"1999","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.jhep.2014.10.039_b0725","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.53.1.14","article-title":"Peroxisome proliferator activated receptor-alpha expression in human liver","volume":"53","author":"Palmer","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jhep.2014.10.039_b0730","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.2337\/dc11-0093","article-title":"Effects of the new dual PPAR alpha\/delta agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism","volume":"34","author":"Cariou","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2014.10.039_b0735","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.2337\/dc12-2012","article-title":"Dual peroxisome proliferator-activated receptor alpha\/delta agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects","volume":"36","author":"Cariou","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2014.10.039_b0740","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.10.039_b0745","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1152\/physiolgenomics.00100.2011","article-title":"Comparative transcriptomic and metabolomic analysis of fenofibrate and fish oil treatments in mice","volume":"43","author":"Lu","year":"2011","journal-title":"Physiol Genomics"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781400806X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781400806X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:34:40Z","timestamp":1759174480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882781400806X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S016882781400806X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.10.039","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}